Abstract
An amendment to this paper has been published and can be accessed via the original article.
The original article can be found online at https://doi.org/10.1186/s40545-020-00219-1.
Correction to: J Pharm Policy Pract (2020) 13:18
https://doi.org/10.1186/s40545-020-00219-1
Following publication of the original article [Citation1], we notified of a mistake in the article’s title.
Correct article title:
Amid COVID-19: the importance of developing a positive reporting culture of adverse drug reaction (ADR) and medical device incident (MDI) for Global Health and public safety
Reference
- Elbeddini A, et al. Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety. J Pharm Policy Pract. 2020;13:18. https://doi.org/10.1186/s40545-020-00219-1.